Valeo Pharma Inc (VPH.TO)
0.115
0.00 (0.00%)
CAD |
TSX |
May 02, 12:16
Valeo Pharma Profit Margin (Quarterly): -50.76% for Jan. 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | -50.76% |
October 31, 2023 | -70.53% |
July 31, 2023 | -41.46% |
April 30, 2023 | -47.77% |
January 31, 2023 | -47.47% |
October 31, 2022 | -73.56% |
July 31, 2022 | -88.61% |
April 30, 2022 | -106.9% |
January 31, 2022 | -140.3% |
October 31, 2021 | -226.8% |
July 31, 2021 | -52.39% |
April 30, 2021 | -70.53% |
January 31, 2021 | -92.75% |
Date | Value |
---|---|
October 31, 2020 | -53.09% |
July 31, 2020 | -108.4% |
April 30, 2020 | -41.42% |
January 31, 2020 | -65.80% |
October 31, 2019 | -111.1% |
July 31, 2019 | -3.58% |
April 30, 2019 | -116.2% |
January 31, 2019 | -54.70% |
October 31, 2018 | -53.09% |
July 31, 2018 | -15.40% |
April 30, 2018 | -208.0% |
January 31, 2018 | -249.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-226.8%
Minimum
Oct 2021
-3.58%
Maximum
Jul 2019
-78.59%
Average
-70.53%
Median
Oct 2023
Profit Margin (Quarterly) Benchmarks
Bausch Health Companies Inc | -1.62% |
Biocure Technology Inc | -- |
Core One Labs Inc | -897.6% |
Nova Mentis Life Science Corp | -649.3% |
Nanosphere Health Sciences Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -63.68% |
Return on Invested Capital | -104.3% |
Gross Profit Margin (Quarterly) | 16.68% |
Operating Margin (Quarterly) | -35.92% |
Return on Net Operating Assets | -63.68% |